Eric Alexander is a partner at Reed Smith LLP, and a member of the Life Sciences Health Industry Group, practicing primarily in the area of product liability litigation for pharmaceutical and medical device companies. Eric’s practice has particularly focused on scientific, medical and regulatory issues in product liability cases, including expert discovery, Daubert motions, and preemption issues.
In addition to pharmaceutical and medical device product liability litigation, he has worked on commercial disputes, False Claims Act cases, disability insurance and personal injury cases involving food and beverage products and also has counselled on product liability actions and insurance coverage litigation. He has worked on cases involving a wide range of products and issues with cases pending in courts in the United States and discovery taken around the world.
In his extensive experience, Eric has personally tried multiple prescription drug cases to verdict and assisted in trying more than a dozen other prescription drug and medical device cases. In addition to preparing numerous prescription drug and medical device cases for trial, he has taken and defended hundreds of fact and expert witnesses and developed novel case theories and defenses.
Also, he has drafted and argued numerous discovery, Daubert, in limine, and dispositive motions, and post-trial motions and appellate briefs. Eric has participated in private jury trials, mediations and settlement discussions for a range of products.
In addition, Eric has supervised teams of associates and paralegals with responsibility for more than 20,000 cases in state and federal courts around the country. In all, he has participated in a range of roles during the life of a serial product liability litigation, as national, regional, local, and trial counsel.
He has been centrally involved in paper and electronic document sweeps and productions, class actions and multidistrict litigation, generic written discovery, depositions of company executives and corporate designees, reports, depositions, and motions practice for generic experts, cross-border discovery, case-specific discovery, trials, appeals, and mass settlements with administrative follow-up.
Eric is particularly known for his work with medical and liability/regulatory experts. He has assisted in responding to government investigations and consulted with a range of pharmaceutical, medical device, and health care clients on liability and regulatory issues.
Eric has been a regular speaker on litigation and product liability issues for a variety of audiences, in addition to giving formal training for co-counsel in serial litigation. Eric is also a member of the Blogging Team for the award-winning Drug and Device Law blog.
- Duke University School of Law, 1995, J.D., Cum Laude, Law and Contemporary Problems, Staff Editor
- Kenyon College, 1992, B.A., History, Magna Cum Laude; Highest Honors and Distinction in History, Phi Beta Kappa
Professional Admissions & Qualifications :
- District of Columbia
Court Admissions :
- Supreme Court – United States
- U.S. District Court – District of Columbia
- U.S. District Court – District of Colorado
- U.S. District Court – Western District of Michigan
Clerkships : Honorable Jon P. McCalla, U.S. District Court – Western District of Tennessee
- Part of national counsel teams in nationwide serial product liability litigation involving prescription weight loss, birth control, diabetes, lactation, Parkinson’s medications, hernia repair devices, pelvic mesh devices, and other medical products since 1997.
- Olmo v. Davol, Inc., No. 13-62260-CIV, 2017 WL 1367231 (S.D. Fla. Apr. 10, 2017), aff’d, 710 F. App’x 861 (11th Cir. 2018)
- Whitfield v. C.R. Bard – Part of a trial team that won a defense verdict in April 2010 in the first MDL bellwether trial concerning a hernia repair product.
- Montgomery v. Wyeth, 540 F. Supp. 2d 933 (E.D. Tenn. 2008), aff’d, 580 F.3d 455 (6th Cir. 2009).
- Colahan v. DuPont Physicians Group – Won defense verdict in two-and-a-half week trial in District of Columbia Superior Court in June 2007 for pharmaceutical company that sponsored a clinical trial.
- Wier v. Wyeth – Part of defense team that secured a low plaintiff verdict in a primary pulmonary hypertension case in the Philadelphia Court of Common Pleas in 2006.
Rate : $$$